reports
Flow Beverage Corp: 1 director
A director at Flow Beverage Corp sold 160,296 shares at 0.220CAD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
EQS-News: Volta Medical wurde in die neueste Richtlinie der führenden ...
EQS-News: Volta Medical SAS / Schlagwort(e): Sonstiges Volta Medical wurde in die neueste Richtlinie der führenden internationalen Gesellschaften für kardiale Elektrophysiologie zur Ablation von Vorhofflimmern aufgenommen 09.05.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Volta Medical wurde in die neueste Richtlinie der führenden internationalen Gesellschaften für kardiale Elektrophysiologie zur Ablation von Vorhofflimmern aufgenommen Die im EP Europace Journal veröffentlichte Richtlinie würdigt die KI-basierte Begle...
Genel Energy PLC: Results of AGM
Genel Energy PLC (GENL) Genel Energy PLC: Results of AGM 09-May-2024 / 13:00 GMT/BST 9 May 2024 Genel Energy plc Results of Annual General Meeting 9 May 2024 The Annual General Meeting of Genel Energy plc was held today, Thursday, 9 May 2024 and the results of the votes by shareholders are set out below. The number of ordinary shares of £0.10p each in the Company in issue at the date of the meeting was 279,402,863 and each share attracted one vote. The results were as follows: Resolutions For % Against % ...
Holding(s) in Company
easyJet plc (EZJ) Holding(s) in Company 09-May-2024 / 13:00 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B7KR2P84 Issuer Name EASYJET PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if applicable) US 4. Details of the shareholder Full name of shareholder(...
EQS-News: Volta Medical Featured in Latest Consensus Statement from Le...
EQS-News: Volta Medical SAS / Key word(s): Miscellaneous Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation 09.05.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation Published in the EP Europace Journal, the consensus statement highlights Volta’s AI Companion and the TAILORED-AF clinical tr...
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Mi...
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones Completed enrollment in izokibep Phase 3 trial in hidradenitis suppurativa and enrollment completion in Phase 2b/3 trial in uveitis expected this month; top line data for both trials now expected by end of third and fourth quarter of 2024, respectively Reported positive proof-of-concept for lonigutamab in thyroid eye disease patients and positive top-line Phase 2b/3 data for izokibep in psoriatic arthritis Cash, cash equivalents, and short-term marketable securities at March 31, 2024 of $678.5 million Company...
Sportradar to Participate in the J.P. Morgan Global Technology, Media ...
Sportradar to Participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 21 ST. GALLEN, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company, today announced that Carsten Koerl, Chief Executive Officer, will participate in the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference at the Westin Boston Seaport District Hotel on Tuesday, May 21, 2024. Mr. Koerl will participate in a fireside chat at 8:10 a.m. EST that morning and that will be webcast...
Bonjour Holdings: 1 director
A director at Bonjour Holdings sold 50,000,000 shares at 0.060HKD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Wells Fargo & Company Announces Full Redemption of its Series S Prefer...
SAN FRANCISCO--(BUSINESS WIRE)-- Wells Fargo & Company (NYSE: WFC) today announced that on June 15, 2024 (which, due to the occurrence of a non-business day, will shift to June 17, 2024), it will redeem all 80,000 outstanding shares (the “Redeemed Series S Preferred Shares”) of its 5.90% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series S (the “Series S Preferred Stock”). The redemption of the Redeemed Series S Preferred Shares will trigger the redemption of the 2,000,000 outstanding shares of the related depositary shares (the “Redeemed Series S Depositary Shares...
Disc Medicine Reports First Quarter 2024 Financial Results and Provide...
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update Presented top-line results from AURORA, the placebo-controlled phase 2 study of bitopertin in erythropoietic porphyrias (EPP), in April 2024On track to deliver additional analyses from BEACON and AURORA in Q2 2024Plan to present updated data from the phase 1b/2 study of DISC-0974 in anemia of myelofibrosis (MF), as well as initial single-ascending dose (SAD) data from the phase 1 study of DISC-3405 in healthy volunteers in Q2 2024Continue to be well-capitalized, ending Q1 2024 with $343M in cash and cash...
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to En...
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership will focus on increasing access to life saving therapies for early-stage melanoma patients. MARLBOROUGH, Mass. and FRANKFURT, Germany, May 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of lab...
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for I...
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension - FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders and other diseases of ...
Perma-Fix Reports Financial Results and Provides Business Update for t...
Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024 ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the first quarter ended March 31, 2024. Mark Duff, President and CEO of the Company, commented, “As previously disclosed, our financial performance in the first quarter of 2024 was impacted by a few temporary headwinds. However, we have seen steady improvement heading into the second quarter and anticipate a ...
WisdomTree Announces Launch of India Equity Hedged Fund (INDH)
NEW YORK--(BUSINESS WIRE)-- WisdomTree, Inc. (NYSE: WT), a global financial innovator, today announces the launch of the WisdomTree India Hedged Equity Fund (INDH) on the NASDAQ. INDH seeks to track the price and yield performance, before fees and expenses, of the WisdomTree India Hedged Equity Index. INDH has an expense ratio of 0.63%. The Index is designed to provide exposure to companies incorporated, listed, and traded in India, while at the same time “hedging” or neutralizing exposure to fluctuations in the value of the Indian rupee relative to the U.S. dollar. “While India’s strong e...
NICE Named the Conversational Intelligence Market Leader in 2024 Opus ...
HOBOKEN, N.J.--(BUSINESS WIRE)-- (Nasdaq: NICE) today announced that Opus Research has named NICE a market leader in Conversational Intelligence (CI) in its 2024 Opus Research Conversational Intelligence Intelliview Report out of 18 vendors evaluated. NICE’s industry leading Enlighten Actions, Enlighten Copilot, Enlighten XO and Enlighten Autopilot were assessed as a part of this research. Opus Research gave NICE the highest possible ratings in three main criteria – Technology and Differentiation, Breadth of Business Impact, and Track Record, Partnerships and Customer Base. Opus Research cl...
ACV to Participate in Upcoming Investor Conferences
ACV to Participate in Upcoming Investor Conferences BUFFALO, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the following upcoming investor conferences: 19th Annual Needham Technology, Media, & Consumer Conference on Thursday, May 16, 2024 at 11:00 a.m. ET52nd Annual J.P. Morgan Global Technology, Media and Communications Conference on Tuesday, May 21, 2024 at 4:25 p.m. ET Webcasts of these events will be a...
Rush Street Interactive to Participate at the Needham Technology, Medi...
Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer Conference CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced that Richard Schwartz, Chief Executive Officer, and Kyle Sauers, Chief Financial Officer, will participate in a fireside chat at Needham’s Technology, Media, & Consumer Conference on Thursday, May 16, 2024 at 1:30 p.m. Eastern Time. Access to the video webcast of the presentation in list...
Xunlei Limited Schedules 2024 Unaudited First Quarter Earnings Release...
Xunlei Limited Schedules 2024 Unaudited First Quarter Earnings Release on May 16, 2024 SHENZHEN, China, May 09, 2024 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2024 before market opens on Thursday, May 16, 2024 . The earnings press release will be available on the Company's investor relations page at Conference Call Xunlei's management will host a conference call at...
Zscaler to Host Third Quarter Fiscal Year 2024 Earnings Conference Cal...
Zscaler to Host Third Quarter Fiscal Year 2024 Earnings Conference Call Earnings Results to be Released on Thursday, May 30, After the Close of the Market SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release third quarter fiscal year 2024 earnings after the market closes on Thursday, May 30, 2024. The company will host an investor conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results. Date:Thursday, May 30th, 2024Time:1:30 p.m. PTWebcast:Dial-in:To join by phone, register at...
Fulcrum Therapeutics to Participate in Upcoming May Conferences
Fulcrum Therapeutics to Participate in Upcoming May Conferences CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences: RBC Capital Market Global Healthcare ConferenceWednesday May 15 at 4:05 p.m. ET. (Fireside Chat)Link to register for the Fireside Chat can be found H.C. Wainwright 2nd Annual BioConnec...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.